- 专利标题： AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
-
申请号： US16295705申请日： 2019-03-07
-
公开(公告)号： US20190276435A1公开(公告)日： 2019-09-12
- 发明人: Stacey Shepard , Andrew P. Combs , Nikoo Falahatpisheh , Lixin Shao
- 申请人： Incyte Corporation
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; C07D403/14 ; C07D403/08 ; C07D413/04 ; C07D417/04 ; C07D405/12 ; C07D241/28 ; C07D241/20 ; C07B59/00 ; A61P35/00 ; A61P9/00 ; A61P25/28 ; A61P37/02
摘要：
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
公开/授权文献
- US10669262B2 Aminopyrazine diol compounds as PI3K-γ inhibitors 公开/授权日：2020-06-02
信息查询
